Guoke Hengtai: Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2025
Securities code: 301370 Securities abbreviation: Guoke Hengtai Announcement number: 2025-083
Guoke Hengtai (Beijing) Medical Technology Co., Ltd.
Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2025
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Special tips:
There is no veto of the resolution at this general meeting of shareholders.
This shareholders’ meeting does not involve changes to the resolutions passed by previous shareholders’ meetings.
1. Meeting convening and attendance
(1) Convening of the meeting
- Meeting time:
On-site meeting time: December 16, 2025 (Tuesday) 14:30 pm
Online voting time: The time for online voting through the Shenzhen Stock Exchange trading system is: 9:15-9:25 am, 9:30-11:30 and 13:00-15:00 pm on December 16, 2025; the specific time for voting through the Shenzhen Stock Exchange Internet system is: any time from 9:15 am to 15:00 pm on December 16, 2025.
Meeting place: Conference Room 410, Building 6, No. 25, Jinghai 4th Road, Beijing Economic and Technological Development Zone, Beijing.
Meeting method: This shareholders’ meeting will adopt a combination of on-site voting and online voting.
Convener of the meeting: The third session of the Board of Directors of the company.
Meeting host: Chairman Mr. Liu Bing presided over the meeting.
The convening and holding of this meeting complied with the relevant provisions of the "Company Law of the People's Republic of China", "Rules of Shareholders' Meetings of Listed Companies" and other relevant laws, administrative regulations, departmental rules, normative documents and the "Articles of Association".
(2) Attendance at meetings
- Overall attendance of shareholders
There were 71 shareholders and shareholder representatives who voted on-site and online, representing 125,014,293 shares, accounting for 26.7717% of the company’s total voting shares. Among them: 4 shareholders and shareholder representatives passed on-site voting, representing 124,342,304 shares, accounting for 26.6278% of the company’s total voting shares. There were 67 shareholders voting online, representing 671,989 shares, accounting for 0.1439% of the company's total voting shares.
- Overall attendance of small and medium shareholders
There were 67 small and medium-sized shareholders voting on site and online, representing 671,989 shares, accounting for 0.1439% of the company’s total voting shares. Among them: 0 small and medium-sized shareholders passed on-site voting, representing 0 shares, accounting for 0.0000% of the company's total voting shares. There were 67 small and medium-sized shareholders voting online, representing 671,989 shares, accounting for 0.1439% of the company's total voting shares.
Note: As of the equity registration date of this shareholders' meeting, the company's total share capital is 470,600,000 shares, of which the number of shares in the company's special securities account for repurchase is 3,635,860 shares. The repurchased shares do not have voting rights, so the total number of shares with voting rights for this shareholders' meeting is 466,964,140 shares.
The above percentage calculation results are rounded to four decimal places. Any difference in the mantissa between the total and the direct sum of each detail is due to rounding.
All directors, supervisors and senior managers of the company attended the meeting, and witnessing lawyers from Beijing Zhonglun Law Firm attended the meeting.
2. Proposal review and voting status
This general meeting of shareholders adopted a combination of on-site registered voting and online voting to consider and approve the following proposals:
- Consider and approve the "Proposal on Amending the Articles of Association"
Total voting results: 124,861,504 shares were approved, accounting for 99.8778% of the total number of shares with valid voting rights present at this shareholders' meeting; 152,389 shares were opposed, accounting for 0.1219% of the total number of shares with valid voting rights present at this shareholders' meeting; 400 shares were abstained (of which 0 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0003%.
This motion is a special resolution matter and was passed by more than 2/3 of the valid voting rights held by shareholders (including shareholders’ proxies) who have attended the shareholders’ meeting.
- Considered and approved the "Proposal on Amending Part of the Company's Management System"
This proposal contains 8 sub-proposals, which need to be voted on one by one. Proposals 2.01 and 2.02 are special resolution matters and need to be passed by more than 2/3 of the valid voting rights held by shareholders (including shareholders’ proxies) attending the shareholders’ meeting.
2.01 The "Proposal on Amending the Rules of Procedure of the Shareholders' Meeting" was considered and approved
Total voting results: 124,769,104 shares were approved, accounting for 99.8039% of the total number of shares with valid voting rights present at this shareholders' meeting; 235,789 shares were opposed, accounting for 0.1886% of the total number of shares with valid voting rights present at this shareholders' meeting; 9,400 shares were abstained (of which 9,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0075%.
This motion is a special resolution matter and was passed by more than 2/3 of the valid voting rights held by shareholders (including shareholders’ proxies) who have attended the shareholders’ meeting.
2.02 Considered and approved the "Proposal on Amending the Rules of Procedure of the Board of Directors"
Total voting results: 124,768,104 shares were approved, accounting for 99.8031% of the total number of shares with valid voting rights present at this shareholders' meeting; 235,789 shares were opposed, accounting for 0.1886% of the total number of shares with valid voting rights present at this shareholders' meeting; 10,400 shares were abstained (of which 10,000 shares abstained by default due to failure to vote), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0083%.
This motion is a special resolution matter and was passed by more than 2/3 of the valid voting rights held by shareholders (including shareholders’ proxies) who have attended the shareholders’ meeting.
2.03 The "Proposal on Amending the Related Party Transaction Management System" was reviewed and approved
Total voting results: 124,765,104 shares were approved, accounting for 99.8007% of the total number of shares with valid voting rights present at this shareholders' meeting; 238,789 shares were opposed, accounting for 0.1910% of the total number of shares with valid voting rights present at this shareholders' meeting; 10,400 shares were abstained (of which 10,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0083%.
2.04 The "Proposal on Amending the External Guarantee Management System" was reviewed and approved
Total voting results: 124,753,104 shares were approved, accounting for 99.7911% of the total number of shares with valid voting rights present at this shareholders' meeting; 238,789 shares were opposed, accounting for 0.1910% of the total number of shares with valid voting rights present at this shareholders' meeting; 22,400 shares were abstained (of which 22,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0179%.
2.05 The "Proposal on Amending the "Foreign Investment Management System"" was reviewed and approved
Total voting results: 124,753,104 shares were approved, accounting for 99.7911% of the total number of shares with valid voting rights present at this shareholders' meeting; 238,789 shares were opposed, accounting for 0.1910% of the total number of shares with valid voting rights present at this shareholders' meeting; 22,400 shares were abstained (of which 22,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0179%.
2.06 The "Proposal on Amending the Measures for the Management of Raised Funds" was reviewed and approved
Total voting results: 124,753,104 shares were approved, accounting for 99.7911% of the total number of shares with valid voting rights present at this shareholders' meeting; 238,789 shares were opposed, accounting for 0.1910% of the total number of shares with valid voting rights present at this shareholders' meeting; 22,400 shares were abstained (of which 22,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0179%.
2.07 The "Proposal on Amending the Management System for Regulating Fund Transactions with Related Parties" was reviewed and approved.
Total voting results: 124,753,104 shares were approved, accounting for 99.7911% of the total number of shares with valid voting rights present at this shareholders' meeting; 238,789 shares were opposed, accounting for 0.1910% of the total number of shares with valid voting rights present at this shareholders' meeting; 22,400 shares were abstained (of which 22,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0179%.
2.08 The "Proposal on Amending the Working System of Independent Directors" was reviewed and approved
Total voting results: 124,756,104 shares were approved, accounting for 99.7935% of the total number of shares with valid voting rights present at this shareholders' meeting; 235,789 shares were opposed, accounting for 0.1886% of the total number of shares with valid voting rights present at this shareholders' meeting; 22,400 shares were abstained (of which 22,000 shares were abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0179%.
- Consider and approve the "Proposal on Hiring an Audit Institution for 2025"
Total voting results: 124,839,504 shares were approved, accounting for 99.8602% of the total number of shares with valid voting rights present at this shareholders' meeting; 152,389 shares were opposed, accounting for 0.1219% of the total number of shares with valid voting rights present at this shareholders' meeting; 22,400 shares were abstained (of which 22,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0179%.
Among them, the total voting results of the small and medium-sized shareholders attending the meeting were: 497,200 shares were approved, accounting for 73.9893% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders’ meeting; 152,389 shares were opposed, accounting for 22.6773% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders’ meeting; 22,400 shares were abstained (of which 22,000 shares were abstained by default due to failure to vote) shares), accounting for 3.3334% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this general meeting of shareholders.
- Considered and approved the "Proposal on Closing Part of the Investment Projects with Raised Funds and Keeping the Surplus Raised Funds in a Special Account for Raised Fund Management"
Total voting results: 124,839,504 shares were approved, accounting for 99.8602% of the total number of shares with valid voting rights present at this shareholders' meeting; 152,389 shares were opposed, accounting for 0.1219% of the total number of shares with valid voting rights present at this shareholders' meeting; 22,400 shares were abstained (of which 22,000 shares abstained by default due to non-voting), accounting for 10% of the total number of shares with valid voting rights present at this shareholders' meeting. 0.0179%.
Among them, the total voting results of the small and medium-sized shareholders attending the meeting were: 497,200 shares were approved, accounting for 73.9893% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders’ meeting; 152,389 shares were opposed, accounting for 22.6773% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders’ meeting; 22,400 shares were abstained (of which 22,000 shares were abstained by default due to failure to vote) shares), accounting for 3.3334% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this general meeting of shareholders.
3. Legal opinions issued by lawyers
Law firm name: Beijing Zhonglun Law Firm
Lawyers’ names: Zheng Yufeng, Zhang Sining
Concluding observations: The convening and convening procedures of the company's shareholders' meeting, the qualifications of the attendees and conveners, and the voting procedures of the meeting are all in compliance with the relevant provisions of the "Company Law of the People's Republic of China" and other laws, regulations, normative documents and the "Articles of Association", and the voting results are legal and valid.
4. Documents for reference
Resolution of the fifth extraordinary general meeting of shareholders of Guoke Hengtai (Beijing) Medical Technology Co., Ltd. in 2025;
"Legal Opinion of Beijing Zhonglun Law Firm on the Fifth Extraordinary General Meeting of Shareholders of Guoke Hengtai (Beijing) Medical Technology Co., Ltd. in 2025".
Announcement is hereby made.
Board of Directors of Guoke Hengtai (Beijing) Medical Technology Co., Ltd.
December 16, 2025